T. Sato, M. . Maekawa, N. Mano, T. Abe, and H. Yamaguchi, “Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19”, J Pharm Pharm Sci, vol. 24, pp. 227–236, May 2021.